Know Labs Stock News

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (OTC: KNWN) is pleased to announce the official launch of its structured client engagement process for Know Labs Technology Licensing (KTL), ensuring a seamle

SEATTLE--(BUSINESS WIRE)--Know Labs Sensor Technology in Steering Wheels Could Curb Impaired Driving. Know Labs Retains Stanbridge Group to Secure Automotive JV Partnerships.

Know Labs (NYSEMKT: KNW ) stock is falling on Wednesday as the company biosensor technologies company launches a public share offering. This public offering has Know Labs selling 28 million shares of

Know Labs has filed proposed terms for a $6 million U.S. IPO uplisting. The firm is developing a non-invasive blood glucose monitoring device and vital signs monitoring system.

Image provided by Know Labs This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Know Labs Inc. (OTCMKTS: KNWN), a med-tech company based in Seattle, is advancing toward what it believes will be the first Federal Drug Administration (FDA)-cleared non-invasive glucose monitoring device. Using radio waves, the Bio-FRID™ can reportedly identify different molecules in the body such as glucose, oxygen, alcohol and metabolized drugs. The company says this has significant implications for the 2 billion people who have diabetes and pre-diabetes, and it''s creating a host of solutions to address the problem. Know Lab’s KnowU, for example, allows patients to measure their glucose concentration levels by simply … Full story available on Benzinga.com

Know Labs, Inc., an emerging leader in non-invasive medical diagnostics, today announced that a new subsidiary created to work with the company’s Artificial Intelligence (AI) Deep Learning Platform has generated initial revenue of approximately $4.2 million from Non-Fungible Token (NFT) sales. This revenue will be used to fund ongoing progress toward development of AI technologies […] The post Know Labs Launches Subsidiary, AI Mind Inc., Generates $4.2 Million in NFT Revenue to Fund Continued Non-Invasive Glucose Monitoring Device Development appeared first on AiThority .

Know Labs, Inc. (OTCMKTS:KNWN)s share price traded down 1.5% on Tuesday . The company traded as low as $1.85 and last traded at $1.97. 17,711 shares were traded during mid-day trading, a decline of 69% from the average session volume of 57,071 shares. The stock had previously closed at $2.00. The stocks 50-day moving average []